Summary of the main pathways dysregulated in S63del nerves
| P5 | P-value | P28 | P-value | 4 mo | P-value | |
| Up-regulated pathways | UPR (stress) | 2.1e-15 | UPR (stress) | 1.8e-7 | Inflammation | 2.7e-6 |
| Cell death | 2.9e-5 | Cell death | 4.4e-4 | |||
| UPR (stress) | 2.1e-3 | |||||
| Early TFa (Oct6, Id2, Sox2) | Early TFa (Oct6, Id2, Sox2, c-Jun) | Early TF* (Oct6, Id2, Sox2, c-Jun) | ||||
| Down-regulated pathways | Lipid biosynthesis | 1.4e-35 | Lipid biosynthesis | 1.8e-7 | Lipid biosynthesis | 8.9e-4 |
| Sterol biosynthesis | 5.6e-28 | Sterol biosynthesis | 2.7e-7 | Sterol biosynthesis | 4.7e-3 | |
| Cholesterol biosynthesis | 3.0e-26 | Cholesterol biosynthesis | 1.6e-4 | Cholesterol biosynthesis | 6.6e-3 |
| P5 | P-value | P28 | P-value | 4 mo | P-value | |
| Up-regulated pathways | UPR (stress) | 2.1e-15 | UPR (stress) | 1.8e-7 | Inflammation | 2.7e-6 |
| Cell death | 2.9e-5 | Cell death | 4.4e-4 | |||
| UPR (stress) | 2.1e-3 | |||||
| Early TFa (Oct6, Id2, Sox2) | Early TFa (Oct6, Id2, Sox2, c-Jun) | Early TF* (Oct6, Id2, Sox2, c-Jun) | ||||
| Down-regulated pathways | Lipid biosynthesis | 1.4e-35 | Lipid biosynthesis | 1.8e-7 | Lipid biosynthesis | 8.9e-4 |
| Sterol biosynthesis | 5.6e-28 | Sterol biosynthesis | 2.7e-7 | Sterol biosynthesis | 4.7e-3 | |
| Cholesterol biosynthesis | 3.0e-26 | Cholesterol biosynthesis | 1.6e-4 | Cholesterol biosynthesis | 6.6e-3 |
Results are based on manual categorization and L2L analysis.
Arbitrary category, not present in L2L or GO. For this reason, Early TF have no p-values.